A. “Safety, tolerability, and antibody response of active A{beta} immunotherapy with CAD106 in patients with Alzheimer’s disease: randomised, double-blind, placebo-controlled, first-in-human study,” by Prof. Bengt Winblad, Niels Andreasen, Prof. Lennart Minthon, Annette Floesser, Georges Imbert, Thomas Dumortier, R. Paul Maguire, Kaj Blennow, Joens Lundmark, Matthias Staufenbiel, Prof. Jean-Marc Orgogozo, and Ana Graf (Vol. 11, No. 7, July 2012, p. 597-604).
www.thelancet.com/journals/laneur/article/PIIS1474-4422%2812%2970140-0/abstract
B. “Methylphenidate for gait hypokinesia and freezing in patients with Parkinson’s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial,” by Caroline Moreau, Arnaud Delval, Luc Defebvre, Kathy Dujardin, Alain Duhamel, Gregory Petyt, Isabelle Vuillaume, Jean-Christophe Corvol, Christine Brefel-Courbon, Fabienne Ory-Magne, Dominique Guehl, Alexandre Eusebio, Valerie Fraix, Pierre-Jean Saulnier, Ouhaid Lagha-Boukbiza, Frank Durif, Mirela Faighel, Caroline Giordana, Sophie Drapier, David Maltete, Christine Tranchant, Jean-Luc Houeto, Bettina Debu, Bernard Sablonniere, Jean-Philippe Azulay, François Tison, Olivier Rascol, Marie Vidailhet, Alain Destee, Bastiaan R. Bloem, Regis Bordet, and Dr. David Devos (Vol. 11, No. 7, July 2012, p. 589-596).
www.thelancet.com/journals/laneur/article/PIIS1474-4422%2812%2970106-0/abstract
